CTLA4 and hepatocellular carcinoma: Therefore, employing single-cell analysis, we compared the expression level variations of EFRGs among various cellular components within the immune microenvironment between samples treated with anti-PDL1/CTLA-4 and control HCC samples (Figure 11A).